World's Best Scientists 2026 revealed!
Brigitte Dreno

Brigitte Dreno

D-Index & Metrics

Medicine

D-Index
115
Citations
77490
World Ranking
4430
National Ranking
131

Overview

Brigitte Dreno is affiliated with the University of Nantes in France and has a significant body of research primarily in the field of medicine, with a strong focus on dermatology.

Their work spans various subfields including:

  • Dermatology
  • Oncology
  • Molecular Biology
  • Epidemiology
  • Immunology

The main research topics covered by their publications include:

  • Acne and Rosacea Treatments and Effects
  • Cutaneous Melanoma Detection and Management
  • Skin Protection and Aging
  • CAR-T cell therapy research
  • Cancer Immunotherapy and Biomarkers
  • Nonmelanoma Skin Cancer Studies
  • Dermatology and Skin Diseases

Brigitte Dreno has contributed to a number of papers, including:

  • "European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment," 2020, European Journal of Cancer
  • "European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022," 2022, European Journal of Cancer
  • "The Skin Microbiome: A New Actor in Inflammatory Acne," 2020, American Journal of Clinical Dermatology
  • "European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022," 2022, European Journal of Cancer
  • "European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention," 2020, European Journal of Cancer

The scientist frequently collaborates with other researchers, including:

  • Amir Khammari
  • M.-T. Leccia
  • Célèste Lebbe
  • Philippe Saïag
  • Delphine Kérob

Publications by Brigitte Dreno appear mainly in the following venues:

  • Journal of the European Academy of Dermatology and Venereology
  • Journal of the American Academy of Dermatology
  • Annales de Dermatologie et de Vénéréologie - FMC
  • Annales de Dermatologie et de Vénéréologie
  • European Journal of Dermatology

Best Publications

  • Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

    Paul B. Chapman;Axel Hauschild;Caroline Robert;John B. Haanen

  • Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

    James Larkin;Vanna Chiarion-Sileni;Rene Gonzalez;Jean Jacques Grob

  • Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

    Keith T. Flaherty;Caroline Robert;Peter Hersey;Paul Nathan

  • Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma

    James Larkin;Paolo A. Ascierto;Brigitte Dréno;Victoria Atkinson

  • Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group

    K T Flaherty;C Robert;P Hersey;P Nathan;P Nathan

  • Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

    Mark R Middleton;J J Grob;N Aaronson;G Fierlbeck

  • Management of Acne: A Report From a Global Alliance to Improve Outcomes in Acne

    Harald Gollnick;William Cunliffe;Diane Berson;Brigitte Dreno

  • New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group

    Diane Thiboutot;Harald Gollnick;Vincenzo Bettoli;Brigitte Dréno

  • Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

    Grant A McArthur;Paul B Chapman;Caroline Robert;James Larkin

  • Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

    M Marchand;N van Baren;N van Baren;P Weynants;P Weynants;V Brichard;V Brichard;V Brichard

  • Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial.

    Paolo A Ascierto;Grant A McArthur;Grant A McArthur;Brigitte Dréno;Victoria Atkinson

  • Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

    Jacques Dantal;Maryvonne Hourmant;Diego Cantarovich;Magali Giral

  • Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

    Antoni Ribas;Richard Kefford;Margaret A. Marshall;Cornelis J.A. Punt

  • Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.

    Elise A. Olsen;Sean Whittaker;Youn H. Kim;Madeleine Duvic

  • A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid

    Pascal Joly;Jean-Claude Roujeau;Jacques Benichou;Catherine Picard

  • Identification of SLC39A4 , a gene involved in acrodermatitis enteropathica

    Sébastien Küry;Brigitte Dréno;Stéphane Bézieau;Stéphanie Giraudet

  • European Evidence‐based (S3) Guidelines for the Treatment of Acne

    Alexander Nast;B. Dréno;V. Bettoli;K. Degitz

  • Defining early mycosis fungoides.

    Nicola Pimpinelli;Elise A. Olsen;Marco Santucci;Eric Vonderheid

  • Randomised trial of interferon α-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases

    Jean Jacques Grob;Brigitte Dreno;Pauline de la Salmoniere;Michele Delaunay

  • Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

    H Miles Prince;H Miles Prince;Youn H Kim;Steven M Horwitz;Reinhard Dummer

Frequent Co-Authors

Grant A. McArthur
Grant A. McArthur Peter MacCallum Cancer Centre
Paolo A. Ascierto
Paolo A. Ascierto National Institutes of Health
Claus Garbe
Claus Garbe University of Tübingen
James Larkin
James Larkin Royal Marsden NHS Foundation Trust
Francine Jotereau
Francine Jotereau University of Nantes
Antoni Ribas
Antoni Ribas University of California, Los Angeles
Axel Hauschild
Axel Hauschild Kiel University
Céleste Lebbé
Céleste Lebbé Hôpitaux Universitaires Paris-Ouest
Dirk Schadendorf
Dirk Schadendorf University of Duisburg-Essen
Michele Maio
Michele Maio University of Siena

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees and career pathways can open up new opportunities in healthcare, whether you are just starting out or looking to advance your career. There are a variety of flexible options available for students interested in specialized areas of medicine or healthcare administration.

Nursing remains a popular choice, and bridge programs like rn to np allow registered nurses with an associate degree to earn a nurse practitioner qualification. For those seeking a faster route to a bachelor's, consider streamlined programs like an rn to bsn online no clinicals option.

If you are passionate about nutrition and wellness, a best online nutrition degree can lead to rewarding roles in clinical settings, public health, or research. Those aiming for healthcare management can pursue a cahme accredited online mha programs list to gain leadership skills and eligibility for administrative positions.

These pathways offer flexibility with online formats, often designed for working professionals or those balancing other commitments. With the right program, you can build a fulfilling career in medicine or allied health fields.

Best Scientists Citing Brigitte Dreno

Trending Scientists